Skip Standard Navigation Links
Centers for Disease Control and Prevention
 CDC Home Search Health Topics A-Z
peer-reviewed.gif (582 bytes)
eid_header.gif (2942 bytes)
Past Issue

Vol. 12, No. 3
March 2006

Adobe Acrobat logo

EID Home | Ahead of Print | Past Issues | EID Search | Contact Us | Announcements | Suggested Citation | Submit Manuscript

PDF Version | Comments Comments | Email this article Email this article



The Study
Conclusions
References
Figure 1
Figure 2

Dispatch

Canine Coronavirus Highly Pathogenic for Dogs

Canio Buonavoglia,*Comments Nicola Decaro,* Vito Martella,* Gabriella Elia,* Marco Campolo,* Costantina Desario,* Massimo Castagnaro,† and Maria Tempesta*
*University of Bari, Bari, Italy; and †University of Padua, Padova, Italy

Suggested citation for this article


Canine coronavirus (CCoV) is usually responsible for mild, self-limiting infections restricted to the enteric tract. We report an outbreak of fatal disease in puppies caused by a pathogenic variant of CCoV that was isolated from organs with severe lesions.

Coronaviruses are large, enveloped, positive-stranded RNA viruses (1). Three different coronaviruses have been identified in dogs (2,3). Canine coronavirus (CCoV) type I and type II are included in group 1 coronaviruses, and their evolution is related to that of feline coronavirus (FCoV) type I and type II. FCoV type II originated by heterologous recombination between CCoV type II and FCoV type I, while CCoV type I is genetically more similar to FCoV type I than to CCoV type II (3). In addition, 2 FCoV biotypes that differ in pathogenicity have been observed in cats.

The onset of acute fatal disease (feline infectious peritonitis) is caused by pantropic variants (able to disseminate throughout the organism) of enteric FCoVs with deletions or recombinations in the 3c and 7b genes at the 3´ end of the FCoV genome (4). Similarly, changes in tissue tropisms in porcine and murine coronaviruses (5,6) and adaptation of the recently recognized severe acute respiratory syndrome–associated coronavirus (7) to humans have been related to mutations or deletions. A third canine coronavirus, CRCoV, detected in the respiratory tract, has <96.0% amino acid (aa) conservation in the spike (S) protein with bovine coronavirus within group 2 coronaviruses, which provides strong evidence for a recent host-species shift (2).

Coronavirus infection in dogs is usually restricted to the enteric tract. The infection is self-limiting and in general produces only mild or asymptomatic forms of enteritis (8). We report the identification of a pantropic, highly pathogenic variant of CCoV type II.

The Study

In May 2005, a severe outbreak of fatal systemic disease occurred in a pet shop in Bari, Italy. Clinical symptoms were initially observed in 3 miniature pinschers (45 days of age) and 1 cocker spaniel (53 days of age) and consisted of fever (39.5°C–40°C), lethargy, inappetence, vomiting, hemorrhagic diarrhea, and neurologic signs (ataxia, seizures) with death after 2 days. The same symptoms were observed 3–4 days later in 2 other miniature pinschers (45 days of age) and 1 Pekinese (56 days of age). Necropsy of the dogs showed hemorrhagic enteritis, abundant serosanguineous fluid in the abdominal cavity, and severe lesions in the parenchymatous organs. The lungs had multiple, patchy, red areas of consolidation. Livers were yellow-brown and congested, with hemorrhages on their surfaces, and spleens were enlarged with subcapsular hemorrhages. Variable gross changes in other organs included multifocal hemorrhagic renal cortical infarcts and petechial hemorrhages on lymph node surfaces.

Figure 1
Figure 1.

Click to view enlarged image

Figure 1. Immunohistochemical detection of canine coronavirus antigen (arrows) in canine lung tissue...

  

Figure 2

Figure 2.
Click to view enlarged image

Figure 2. Neighbor-joining tree of the spike protein of canine coronavirus (CCoV) and feline coronavirus (FCoV)...

Virologic and bacteriologic investigations on the parenchymatous organs did not detect common canine pathogens, notably canine parvovirus type 2, canine distemper virus, canine adenovirus type 1 and type 2. CCoV type I and type II were identified in the intestinal contents of all puppies by genotype-specific real-time reverse transcription–polymerase chain reaction (RT-PCR) assays (9). CCoV type II RNA was also detected in lungs (median 1.08 × 106 RNA copies/μL of template), spleen (median 4.46 × 106 RNA copies/μL of template), liver (median 9.02 × 104 RNA copies/μL of template), kidney (median 7.54 × 104 RNA copies/μL of template), and brain (median 5.23 × 103 RNA copies/μL of template). Virus-induced cytopathic effect was observed in A-72 cells, and CCoV type II strain (CB/05) was isolated from all tissues examined except brain tissue. Immunohistochemical analysis with a CCoV-specific monoclonal antibody detected CCoV antigen in the organs with gross lesions that were examined (lungs, kidneys, liver, spleen, gut, and lymph nodes) (Figure 1).

The sequence of the 3´ end of the genome (8.8 kb) of the pantropic CCoV strain was determined by RT-PCR amplification and sequencing of overlapping fragments. The S, envelope, and membrane proteins and nucleoprotein showed a high degree of amino acid identity with the cognate open reading frame (ORF) of CCoV type II. The S protein of strain CB/05 had the highest identity to FCoV type II strain 79-1683 (Figure 2). Comparison with strain CB/05 was possible only with CCoV type II strains Insavc-1 (10) and BGF (11) and CCoV type I strains Elmo/02 and 23/03 (3,12) because of a lack of data on  the 3´ end of the CCoV genome in the genes encoding for nonstructural proteins (NSPs) 3a, 3b, 3c, 7a, and 7b. NSPs 3a, 7a, and 7b were not altered. NSP 3b (22 aa) was 49 aa shorter than expected because of a 38-nucleotide deletion and a frame shift mutation in the downstream sequence that introduced an early stop codon. NSP 3c (244 aa) was 6 aa shorter and 79 aa longer than the cognate proteins of the enteropathogen strain BGF and the attenuated strain Insavc-1a, respectively.

To confirm the pathogenic potential of strain CB/05, we experimentally infected two 6-month-old dogs (authorization no. 67/2002-C released by Ministry of Health of Italy). Two milliliters of cryolysate of a lung-derived first-passage virus in A-72 cells were administered intranasally to the dogs. The cell cryolysate tested negative for other common canine pathogens and had a 50% tissue culture infectious dose of 105.50/50 μL on A-72 cells and 1.18 × 107 RNA copies/μL of template by real-time RT-PCR. The virus was reisolated from the experimentally infected dogs. Severe clinical symptoms characterized by pyrexia (temperature 39.8°C–40.1°C), anorexia, depression, vomiting, diarrhea, and leukopenia were observed that persisted 8–10 days. Despite the severe symptoms, the dogs slowly recovered from their illness.

Conclusions

Point mutations or deletions in the S protein and NSPs have been associated with changes in tropism and virulence of coronaviruses (4–7,13). CCoV strain CB/05 showed intact structural and nonstructural proteins, with an S protein closely related to that of other type II CCoVs. The only striking change was the truncated form of NSP 3b. Whether the deletion in the ORF of NSP 3b is involved in pathobiologic changes should be assessed with reverse genetic systems.

The present study describes for the first time the occurrence of fatal infections in dogs by coronaviruses. Experimental infection of dogs with the virus isolate resulted in a severe systemic disease that mimicked the clinical symptoms observed in the outbreak. However, the different ages at infection (6 months vs. <2 months) likely resulted in the disease being nonfatal. Accordingly, the appearance of pathogenic CCoV variants should always be regarded as a potential threat to domestic dogs and considered when unexplainable fatal disease outbreaks occur in puppies.

Epidemiologic studies are required to determine whether the pantropic CCoV strain is a new coronavirus variant emerging in canine populations or a widespread infectious agent of dogs that usually goes undetected. Vaccination trials could also help determine whether the CCoV vaccines currently available are effective against the highly virulent CCoV strain.

The 2002–2003 SARS epidemic has demonstrated that the study of animal coronaviruses is paramount to understanding the ecology and evolution of human coronaviruses. The coronaviruses of carnivores provide a paradigmatic model of how coronaviruses cross the species barriers, adapt to new host species, and change their pathogenicity.

This work was supported by grants from the Ministry of Health of Italy (Ricerca corrente 2003: Studio del coronavirus del cane come modello animale per le ricombinazioni genetiche dei coronavirus).

Dr Buonavoglia is professor of veterinary medicine at the University of Bari. His research interests include the study of viral pathogens of dogs, with particular emphasis on canine coronavirus.

References

  1. Lai MMC, Holmes KV. Coronaviridae: the viruses and their replication. In: Knipe DM, Howley PM, editors. Fields virology. 4th ed. Philadelphia: Lippincott Williams and Wilkins; 2001. p. 1163–85.
  2. Erles K, Toomey C, Brooks HW, Brownlie. J. Detection of a group 2 coronavirus in dogs with canine infectious respiratory disease. Virology. 2003;310:216–23.
  3. Pratelli A, Martella V, Decaro N, Tinelli A, Camero M, Cirone F, et al. Genetic diversity of a canine coronavirus detected in pups with diarrhoea in Italy. J Virol Methods. 2003;110:9–17.
  4. Vennema H, Poland A, Foley J, Pedersen NC. Feline infectious peritonitis viruses arise by mutation from endemic feline enteric coronaviruses. Virology. 1998;243:150–7.
  5. Laude H, van Reeth K, Pensaert M. Porcine respiratory coronavirus: molecular features and virus-host interactions. Vet Res. 1993;24:125–50.
  6. Haspel MV, Lampert PW, Oldstone MB. Temperature-sensitive mutants of mouse hepatitis virus produce a high incidence of demyelination. Proc Natl Acad Sci U S A. 1978;75:4033–36.
  7. Guan Y, Zheng BJ, He YQ, Liu XL, Zhuang ZX, Cheung CL, et al. Isolation and characterization of viruses related to the SARS coronavirus from animals in southern China. Science. 2003;302:276–8.
  8. Tennant BJ, Gaskell RM, Kelly DF, Carter SD, Gaskell CJ. Canine coronavirus infection in the dog following oronasal inoculation. Res Vet Sci. 1991;51:11–8.
  9. Decaro N, Martella V, Ricci D, Elia G, Desario C, Campolo M, et al. Genotype-specific fluorogenic RT-PCR assays for the detection and quantitation of canine coronavirus type I and type II RNA in faecal samples of dogs. J Virol Methods. 2005;130:72–8.
  10. Horsburgh BC, Brierley I, Brown TD. Analysis of a 9.6 kb sequence from the 3´ end of canine coronavirus genomic RNA. J Gen Virol. 1992;73:2849–62.
  11. Sanchez-Morgado JM, Poynter S, Morris TH. Molecular characterization of a virulent canine coronavirus BGF strain. Virus Res. 2004;104:27–31.
  12. Pratelli A, Decaro N, Tinelli A, Martella V, Elia G, Tempesta M, et al. Two genotypes of canine coronavirus simultaneously detected in fecal samples of dogs with diarrhea. J Clin Microbiol. 2004;42:1797–9.
  13. Jonassen CM, Kofstad T, Larsen IL, Lovland A, Handeland K, Follestad A, et al. Molecular identification and characterization of novel coronaviruses infecting graylag geese (Anser anser), feral pigeons (Columbia livia) and mallards (Anas platyrhynchos). J Gen Virol. 2005;86:1597–607.

 

Suggested citation for this article:
Buonavoglia C, Decaro N, Martella V, Elia G, Campolo M, Desario C, et al. Canine coronavirus highly pathogenic for dogs. Emerg Infect Dis [serial on the Internet]. 2006 Mar [date cited]. Available from http://www.cdc.gov/ncidod/EID/vol12no03/05-0839.htm

   
     
   
Comments to the Authors

Please use the form below to submit correspondence to the authors or contact them at the following address:

Canio Buonavoglia, Department of Animal Health and Well-being, Faculty of Veterinary Medicine, University of Bari, Strada per Casamassima Km 3, 70010 Valenzano, Bari, Italy; fax: 39-080-467-9843; email: c.buonavoglia@veterinaria.uniba.it

Please note: To prevent email errors, please use no web addresses, email addresses, HTML code, or the characters <, >, and @ in the body of your message.

Return email address optional:


 


Comments to the EID Editors
Please contact the EID Editors at eideditor@cdc.gov

Email this article

Please note: To prevent email errors, please use no web addresses, email addresses, HTML code, or the characters <, >, and @ in the body of your message.

Your email:

Your friend's email:

Message (optional):

 

 

 

EID Home | Top of Page | Ahead-of-Print | Past Issues | Suggested Citation | EID Search | Contact Us | Accessibility | Privacy Policy Notice | CDC Home | CDC Search | Health Topics A-Z

This page posted February 2, 2006
This page last reviewed February 24, 2006

Emerging Infectious Diseases Journal
National Center for Infectious Diseases
Centers for Disease Control and Prevention